Qulipta Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Qulipta
S
- sacubitril / valsartan
- Saizen (somatropin)
- Sandimmune (cyclosporine)
- Sandostatin (octreotide)
- Sandostatin LAR Depot (octreotide)
- saquinavir
- Scemblix (asciminib)
- Se-Donna PB HYOS (atropine / hyoscyamine / phenobarbital / scopolamine)
- secobarbital
- Seconal Sodium (secobarbital)
- Sedapap (acetaminophen / butalbital)
- selinexor
- selpercatinib
- Serostim (somatropin)
- Servira (atropine / hyoscyamine / phenobarbital / scopolamine)
- Serzone (nefazodone)
- Sesquient (fosphenytoin)
- Sezaby (phenobarbital)
- Signifor (pasireotide)
- Signifor LAR (pasireotide)
- simeprevir
- Skyclarys (omaveloxolone)
- Skytrofa (lonapegsomatropin)
- sodium phenylbutyrate / taurursodiol
- sofosbuvir / velpatasvir / voxilaprevir
- Sogroya (somapacitan-beco)
- Solfoton (phenobarbital)
- Solurex (dexamethasone)
- Solurex LA (dexamethasone)
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- Somatuline Depot (lanreotide)
- sotorasib
- Spasmolin (atropine / hyoscyamine / phenobarbital / scopolamine)
- Spasquid (atropine / hyoscyamine / phenobarbital / scopolamine)
- Spastrin (belladonna / ergotamine / phenobarbital)
- Sporanox (itraconazole)
- Sprycel (dasatinib)
- st. john's wort
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Sulfimycin (erythromycin / sulfisoxazole)
- sulfinpyrazone
- Sunlenca (lenacapavir)
- Sustiva (efavirenz)
- suvorexant
- Symdeko (ivacaftor / tezacaftor)
- Symfi (efavirenz / lamivudine / tenofovir)
- Symfi Lo (efavirenz / lamivudine / tenofovir)
- Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide)
- Synercid (dalfopristin / quinupristin)
More about Qulipta (atogepant)
- Qulipta consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (134)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.